+49 711 500 989 80
deen

Novel antiviral drug combinations demonstrate COVID-19 therapeutic potential



Novel antiviral drug combinations demonstrate COVID-19 therapeutic potential

Researchers demonstrate that combinations of antiviral drugs inhibiting both polymerase and exonuclease reduce SARS-CoV-2 replication 10 times more than polymerase inhibitors alone.

Materials provided by Columbia University School of Engineering and Applied Science. Original written by Holly Evarts. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

20th May 2022

Killer T vs. memory — DNA isn't destiny for T cells

Read more
19th May 2022

Epilepsy drug stops nervous system tumor growth in mice

Read more
19th May 2022

Researchers find another layer to the code of life

Read more